There has been an error retrieving the data. Please try again.



View more comments

Aims & scope

Clinical and Molecular Allergy will temporarily cease publication at the end of 2013 and will re-launch during the course of 2014 with a new focus on molecular allergy and clinical applications of molecular techniques.

Topics of interest include, but are not limited to:

  • Diagnostics (component resolved diagnostics, allergen extract diagnostics)
  • Structural biology of allergens (and their interactions with the immune system)
  • Crystallography of allergens
  • Bioinformatics of allergens
  • Epitopes and mimotopes
  • Genetics and epigenetics
  • Therapeutics using molecular techniques
  • Effect of the microbiome on development of allergic disease

Submissions are welcomed, but please note that until a new Editor-in-Chief has been appointed it will not be possible to process manuscripts through peer-review.


Call for Editor-in-Chief

We are currently looking for an Editor-in-Chief to lead Clinical and Molecular Allergy into this exciting new chapter. If you would like to be considered for the role of Editor-in-Chief for the journal, please send your CV along with a letter of application including a statement about your interest in the role and proposed contributions as well as details of your previous editorial experience, to

Submit a manuscript Sign up for article alerts Contact us Support

Email updates

Receive periodic news and updates relating to this journal straight to your inbox.

Indexed by

  • CABI
  • CAS
  • Embase
  • PubMed
  • PubMed Central
  • Scopus

View all

ISSN: 1476-7961